Revolutionizing Drug Development with AI and Whole Genome Sequencing

The Pharmacognosy Drug Discovery and Genomics Division of the Rotger Research Foundation aims to employ the power of artificial intelligence (AI), whole genome sequencing, and pharmacognosy to revolutionize the development of novel, safe, and effective drugs. This division will explore global biodiversity to discover plant species with medicinal potential and translate them into innovative therapeutics.

Key components:

1. Global Biodiversity Exploration — ethical, sustainable sampling with local collaboration.

2. Genomic Analysis & Sequencing — uncover molecular bases of bioactivity and candidate compounds.

3. AI-Driven Discovery — virtual screening, target prediction, lead optimization.

4. Multi-omics Integration — genomics, transcriptomics, proteomics, metabolomics.

5. In Vitro / In Vivo Testing — rigorous, ethical evaluation of safety, efficacy, PK.

6. Clinical Trial Design — regulatory-aligned studies to ensure safety and efficacy.

7. Knowledge Sharing & Partnerships — academia, industry, and research networks.

8. Continuous R&D — refine pipelines, adopt novel methods, expand datasets.

A Novel Approach to Drug Development

Why it’s needed: accelerate discovery, reduce cost, increase success rates, and identify novel plant-derived compounds to advance precision medicine.

How we’ll do it:

1. Phytochemical Profiling & Bioactivity Screening across disease models.

2. Multi-Layered AI Analysis (ML/DL/network methods) for deep pattern discovery.

3. Systems Pharmacology Modeling to predict efficacy, safety, and combinations.

4. Drug Repurposing & Optimization using AI-guided SAR and ADME improvements.

5. Digital Twin Simulation for rapid in-silico iteration prior to preclinical/clinical phases.

6. Collaborative Ecosystem spanning academia, industry, and regulators.

PDD-GD — Global Impact Strategy

We aim to accelerate plant-based therapeutics while expanding equitable access.

1. Strengthen Global Collaboration with institutions and agencies.

2. Capacity Building & Training for a skilled, future-ready workforce.

3. Open Innovation via data and findings to speed breakthroughs.

4. Focus on Underserved Populations and neglected diseases.

5. Sustainable, Ethical Biodiversity Exploration and fair benefit-sharing.

6. Public Awareness & Advocacy to grow support and informed policy.

7. Ongoing R&D investment in AI, genomics, and platform tech.

8. Tailored Regulatory Frameworks with agencies for safe, efficient approvals.

Support the Pharmacognosy Drug Discovery & Genomics Division

Your gifts fuel cutting-edge R&D, training, global collaboration, ethical biodiversity exploration, and research on underserved conditions.

Donate: Support Our Mission: DONATE HERE

Questions? Contact us at info@RotgerResearchFoundation.org.